top of page

Welcome from the AMC  2023 Co-Chairs

We warmly welcome you to the 2023 Australasian Melanoma Conference (AMC 2023), the first in-person AMC since 2018 and the first to be hosted in Brisbane, at the Brisbane Convention and Exhibition Centre on 24th and 25th March.

An initiative of the Melanoma Institute Australia (MIA), this year’s conference is hosted by the Australian Skin and Skin Cancer Research Centre (ASSC), bringing together clinicians, researchers, and consumers. AMC 2023 will kick off with a plenary talk on “Evolution of Melanoma Diagnosis” followed by a consumer panel to discuss the issues in melanoma diagnosis for patients. Later sessions will cover developments in basic sciences, epidemiology, diagnosis and overdiagnosis, surgery, treatments for advanced melanoma, and recent advances in clinical practice. Our second plenary session on Saturday will focus on the most relevant topic at this time, neoadjuvant treatment for advanced stage melanoma.

On behalf of the Executive and Program Committees, we thank our sponsors for their support and we look forward to seeing all of those, in the scientific, medical and consumer community, interested in dealing with Melanoma, in March 2023.

AMC2023 is proudly sponsored by

Platinum Partners

BMS Logo 2020.png

Gold Partner

Bronze Partner 

ALKS logo color_300x300.jpg
Sanofi Logo JPG (1).jpg


Propaira logo - Sun Protection and DNA Repair.jpg

The Australasian Melanoma Conference (AMC) 2023 was held at the Brisbane Convention & Exhibition Centre (BCEC) on 24 and 25 March.

The conference was hosted by the Australian Skin and Skin Cancer Research Centre (ASSC) – a partnership of the University of Queensland and the QIMR Berghofer Research Institute – which aimed to harness the combined strengths of the two institutions with world-leading teams of skin cancer researchers.

bottom of page